JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on April 28, 2026. Further, the company has informed the Exchange regarding voting results.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
JB Chemicals & Pharmaceuticals shareholders approved, with overwhelming support, the proposed Scheme of Amalgamation with Torrent Pharmaceuticals Limited at the NCLT-convened meeting held on April 28, 2026. Promoters voted 100% in favor (7.83 crore shares), while public shareholders approved the scheme 99.02% in favor and only 0.98% against (just 2,185 shares voted against out of 5.20 crore polled). The resolution was passed by the required three-fourths majority in value under Section 230(6) of the Companies Act and also cleared the SEBI public shareholder threshold test. A total of 13.04 crore equity shares were polled, with 99.998% in favor of the merger. The scheme now moves to the next stage of NCLT approval for the amalgamation to take effect.
This is a key milestone in the JB Pharma–Torrent Pharma merger — shareholder approval clears the way for NCLT sanction. Once effective, JB Pharma shareholders will likely receive shares of Torrent Pharma as per the swap ratio, making this a significant event for the stock and shareholder composition.